• Featured Product
  • KD/KO Validated

HMGB3 Polyclonal antibody

HMGB3 Polyclonal Antibody for WB, IF/ICC, ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, IF/ICC, ELISA

Conjugate

Unconjugated

Cat no : 27465-1-AP

Synonyms

high mobility group box 3, High mobility group protein 2a, High mobility group protein 4, High mobility group protein B3, HMG 2a, HMG 4, HMG2A, HMG4, HMGB3



Tested Applications

Positive WB detected inBGC-823 cells, MCF-7 cells, SGC-7901 cells, human placenta tissue
Positive IF/ICC detected inMCF-7 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:500-1:2000
Immunofluorescence (IF)/ICCIF/ICC : 1:200-1:800
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

27465-1-AP targets HMGB3 in WB, IF/ICC, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Cited Reactivityhuman
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen HMGB3 fusion protein Ag26361
Full Name high-mobility group box 3
Calculated Molecular Weight 200 aa, 23 kDa
Observed Molecular Weight 25 kDa
GenBank Accession NumberBC070482
Gene Symbol HMGB3
Gene ID (NCBI) 3149
RRIDAB_2880878
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

HMGB3, also named HMG2A and HMG4, belongs to the HMGB family. HMGB3 binds to nucleosomes in a sequence-independent manner and participates in DNA repair, replication, transcription, and recombination. HMGB3 is highly expressed in stem cells and cancer cells and is rarely transactivated in normal adult tissues, making it a promising therapeutic target. Overexpressed HMGB3 is closely related to tumor occurrence and reduced survival in cervical cancer, non-small-cell lung cancer, breast cancer, bladder cancer, hepatocellular carcnoma, colorectal cancer, gastric cancer, and leukemia (PMID: 35332131).

Protocols

Product Specific Protocols
WB protocol for HMGB3 antibody 27465-1-APDownload protocol
IF protocol for HMGB3 antibody 27465-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Front Cell Dev Biol

HMGB3 is a Potential Therapeutic Target by Affecting the Migration and Proliferation of Colorectal Cancer.

Authors - Wenjing Gong
  • KD Validated
humanWB

Genes (Basel)

Transcriptional Regulation of CD40 Expression by 4 Ribosomal Proteins via a Functional SNP on a Disease-Associated CD40 Locus.

Authors - Meijuan Zou
  • KD Validated
humanWB

Int J Gen Med

Circular RNA 0001313 Knockdown Suppresses Non-Small Cell Lung Cancer Cell Proliferation and Invasion via the microRNA-452/HMGB3/ERK/MAPK Axis.

Authors - Shihao Zhang
humanWB

J Exp Clin Cancer Res

Targeting HMGB3/hTERT axis for radioresistance in cervical cancer.

Authors - Zongjuan Li
humanWB

Front Oncol

Loss of exosomal micro-RNA-200b-3p from hypoxia cancer-associated fibroblasts reduces sensitivity to 5-flourouracil in colorectal cancer through targeting high-mobility group box 3

Authors - Hang Yuan
humanWB

Curr Med Sci

Overexpression of MiR-633 Suppresses the Tumorigenicity of Gastric Cancer Cells and Induces Apoptosis by Targeting MAPK1

Authors - Hai-Long Li

Reviews

The reviews below have been submitted by verified Proteintech customers who received an incentive for providing their feedback.


FH

Ting (Verified Customer) (10-18-2023)

The Antibody looked bad. I saw many non-specific bands and two bands near the HMGB3 molecular weight when I use this antibody. It is really hard to distinguish the bands, especially for Wild-type group.

  • Applications: Western Blot
HMGB3 Antibody Western Blot validation ( dilution) in (Cat no:27465-1-AP)